IP Library › Granted Patent US 7,872,114
Granted Patent B2
US 7,872,114 · App. 10/986,582 · Granted Jan 18, 2011

Immunogenic detoxified mutants of cholera toxin

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,872,114
App. No.
10/986,582
Granted
Jan 18, 2011
Kind
B2
Abstract

An immunogenic detoxified protein comprising the amino acid sequence of subunit A of a cholera toxin (CT-A) or a fragment thereof or the amino acid sequence of subunit A of an Escherichia coli heat labile toxin (LT-A) or a fragment thereof wherein the amino acids at, or in positions corresponding to Ser-63 and Arg-192 are replaced with another amino acid. The immunogenic detoxified protein is useful as vaccine for Vibrio cholerae or an enterotoxigenic strain of Escherichia coli and is produced by recombinant DNA means by site-directed mutagenesis.

Claims (13)

1. A DNA molecule encoding an immunogenic detoxified protein which comprises the amino acid sequence of subunit A of a cholera toxin (CT-A) or the amino acid sequence of subunit A of an Escherichia coli heat labile toxin (LT-A) wherein the amino acid at the position corresponding to Ser-63 of the mature wild-type sequence is replaced with lysine and the amino acid at the position corresponding to Arg-192 of the mature wild-type sequence is replaced with glycine, and further wherein

(i) the immunogenic detoxified protein is more resistant to trypsin proteolysis than wild type CT-A or LT-A;

(ii) the immunogenic detoxified protein exhibits reduced toxicity as compared to a CT or LT subunit A protein in which only the amino acid residue Arg-192 is replaced with glycine; and

(iii) the immunogenic detoxified protein exhibits enhanced immunogenicity as compared to a CT or LT subunit A protein in which the amino acid residue Ser-63 is replaced with lysine.

2. A vector carrying the DNA molecule according to claim 1 .

3. A host cell line transformed with the vector according to claim 2 .

4. The DNA molecule of claim 1 , said molecule encoding an immunogenic detoxified protein which comprises the amino acid sequence of subunit A of a cholera toxin (CT-A).

5. The DNA molecule of claim 1 , wherein the detoxified protein has a toxicity of less than 0.01% of the naturally occurring toxin counterpart.

6. The DNA molecule of claim 4 , said DNA molecule further encoding for at least one CT subunit B.

7. The DNA molecule of claim 6 , wherein said subunit A and said subunit B comprise a polycistronic unit.

8. The DNA molecule of claim 1 , said DNA molecule further encoding for at least one LT subunit B.

9. The DNA molecule of claim 8 , wherein said subunit A and said subunit B comprise a polycistronic unit.

10. A process for the production of the immunogenic detoxified protein of claim 1 , comprising culturing a host cell expressing the DNA molecule of claim 1 and isolating the protein expressed by said DNA molecule.